HERTFORDSHIRE, England and PITTSBURGH, May 17, 2019 /PRNewswire/ -- Mylan N.V. (NASDAQ: MYL) yesterday presented at the Bank of America Merrill Lynch Healthcare Conference, where the company announced that it will host an Investor Day on July 31, 2019 in New York City.
CEO Heather Bresch and Mylan's senior leadership team will share the company's long-term strategic plan, including a strong focus on sustaining profitable growth. As an incremental overlay to the strategic plan, leaders also will provide additional detail on the company's plans to refine its product portfolio, new product launch priorities, commercial focus and operations configuration resulting from their in-depth review of market economics and trends and Mylan's competitive position. Mylan remains confident in its mission to provide access to medicine and looks forward to the opportunity to lead a focused discussion around its commitment to unlocking latent value within the organization and maximizing shareholder return.
Mylan is a global pharmaceutical company committed to setting new standards in healthcare. Working together around the world to provide 7 billion people access to high quality medicine, we innovate to satisfy unmet needs; make reliability and service excellence a habit; do what's right, not what's easy; and impact the future through passionate global leadership. We offer a growing portfolio of more than 7,500 marketed products around the world, including antiretroviral therapies on which more than 40% of people being treated for HIV/AIDS globally depend. We market our products in more than 165 countries and territories. We are one of the world's largest producers of active pharmaceutical ingredients. Every member of our approximately 35,000-strong workforce is dedicated to creating better health for a better world, one person at a time. Learn more at Mylan.com. We routinely post information that may be important to investors on our website at investor.mylan.com.